Literature DB >> 25755286

Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia.

Claire E J Moore1, Halina Mikolajek1, Sergio Regufe da Mota1, Xuemin Wang1, Justin W Kenney1, Jörn M Werner1, Christopher G Proud2.   

Abstract

Protein synthesis, especially translation elongation, requires large amounts of energy, which is often generated by oxidative metabolism. Elongation is controlled by phosphorylation of eukaryotic elongation factor 2 (eEF2), which inhibits its activity and is catalyzed by eEF2 kinase (eEF2K), a calcium/calmodulin-dependent α-kinase. Hypoxia causes the activation of eEF2K and induces eEF2 phosphorylation independently of previously known inputs into eEF2K. Here, we show that eEF2K is subject to hydroxylation on proline-98. Proline hydroxylation is catalyzed by proline hydroxylases, oxygen-dependent enzymes which are inactivated during hypoxia. Pharmacological inhibition of proline hydroxylases also stimulates eEF2 phosphorylation. Pro98 lies in a universally conserved linker between the calmodulin-binding and catalytic domains of eEF2K. Its hydroxylation partially impairs the binding of calmodulin to eEF2K and markedly limits the calmodulin-stimulated activity of eEF2K. Neuronal cells depend on oxygen, and eEF2K helps to protect them from hypoxia. eEF2K is the first example of a protein directly involved in a major energy-consuming process to be regulated by proline hydroxylation. Since eEF2K is cytoprotective during hypoxia and other conditions of nutrient insufficiency, it may be a valuable target for therapy of poorly vascularized solid tumors.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25755286      PMCID: PMC4405635          DOI: 10.1128/MCB.01457-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

2.  Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells.

Authors:  Eileen Connolly; Steve Braunstein; Silvia Formenti; Robert J Schneider
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

3.  AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity.

Authors:  Christine M Chresta; Barry R Davies; Ian Hickson; Tom Harding; Sabina Cosulich; Susan E Critchlow; John P Vincent; Rebecca Ellston; Darren Jones; Patrizia Sini; Dominic James; Zoe Howard; Phillippa Dudley; Gareth Hughes; Lisa Smith; Sharon Maguire; Marc Hummersone; Karine Malagu; Keith Menear; Richard Jenkins; Matt Jacobsen; Graeme C M Smith; Sylvie Guichard; Martin Pass
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

4.  Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1).

Authors:  Marianne Tiainen; Kari Vaahtomeri; Antti Ylikorkala; Tomi P Mäkelä
Journal:  Hum Mol Genet       Date:  2002-06-15       Impact factor: 6.150

5.  AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress.

Authors:  Kazuo Terai; Yoshimune Hiramoto; Mitsuru Masaki; Shoko Sugiyama; Tadashi Kuroda; Masatsugu Hori; Ichiro Kawase; Hisao Hirota
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

6.  Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy.

Authors:  Christoph Loenarz; Rok Sekirnik; Armin Thalhammer; Wei Ge; Ekaterina Spivakovsky; Mukram M Mackeen; Michael A McDonough; Matthew E Cockman; Benedikt M Kessler; Peter J Ratcliffe; Alexander Wolf; Christopher J Schofield
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

7.  The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.

Authors:  Gabriel Leprivier; Marc Remke; Barak Rotblat; Adrian Dubuc; Abigail-Rachele F Mateo; Marcel Kool; Sameer Agnihotri; Amal El-Naggar; Bin Yu; Syam Prakash Somasekharan; Brandon Faubert; Gaëlle Bridon; Cristina E Tognon; Joan Mathers; Ryan Thomas; Amy Li; Adi Barokas; Brian Kwok; Mary Bowden; Stephanie Smith; Xiaochong Wu; Andrey Korshunov; Thomas Hielscher; Paul A Northcott; Jason D Galpin; Christopher A Ahern; Ye Wang; Martin G McCabe; V Peter Collins; Russell G Jones; Michael Pollak; Olivier Delattre; Martin E Gleave; Eric Jan; Stefan M Pfister; Christopher G Proud; W Brent Derry; Michael D Taylor; Poul H Sorensen
Journal:  Cell       Date:  2013-05-23       Impact factor: 41.582

8.  Proteasomal degradation of eukaryotic elongation factor-2 kinase (EF2K) is regulated by cAMP-PKA signaling and the SCFβTRCP ubiquitin E3 ligase.

Authors:  Shari L Wiseman; Yoshio Shimizu; Clive Palfrey; Angus C Nairn
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

9.  An oxygen-regulated switch in the protein synthesis machinery.

Authors:  James Uniacke; Chet E Holterman; Gabriel Lachance; Aleksandra Franovic; Mathieu D Jacob; Marc R Fabian; Josianne Payette; Martin Holcik; Arnim Pause; Stephen Lee
Journal:  Nature       Date:  2012-05-06       Impact factor: 49.962

10.  OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.

Authors:  Rachelle S Singleton; Phebee Liu-Yi; Fabio Formenti; Wei Ge; Rok Sekirnik; Roman Fischer; Julie Adam; Patrick J Pollard; Alexander Wolf; Armin Thalhammer; Christoph Loenarz; Emily Flashman; Atsushi Yamamoto; Mathew L Coleman; Benedikt M Kessler; Pablo Wappner; Christopher J Schofield; Peter J Ratcliffe; Matthew E Cockman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

View more
  31 in total

Review 1.  Phosphorylation and Signal Transduction Pathways in Translational Control.

Authors:  Christopher G Proud
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

Review 2.  Cross-talk between protein synthesis, energy metabolism and autophagy in cancer.

Authors:  Lisa M Lindqvist; Kristofferson Tandoc; Ivan Topisirovic; Luc Furic
Journal:  Curr Opin Genet Dev       Date:  2017-11-25       Impact factor: 5.578

3.  Structural Basis for the Recognition of Eukaryotic Elongation Factor 2 Kinase by Calmodulin.

Authors:  Kwangwoon Lee; Sébastien Alphonse; Andrea Piserchio; Clint D J Tavares; David H Giles; Rebecca M Wellmann; Kevin N Dalby; Ranajeet Ghose
Journal:  Structure       Date:  2016-08-04       Impact factor: 5.006

4.  Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress.

Authors:  Jianling Xie; Petra Van Damme; Danielle Fang; Christopher G Proud
Journal:  J Biol Chem       Date:  2019-03-19       Impact factor: 5.157

5.  The prohibitin-binding compound fluorizoline affects multiple components of the translational machinery and inhibits protein synthesis.

Authors:  Xin Jin; Jianling Xie; Michael Zabolocki; Xuemin Wang; Tao Jiang; Dong Wang; Laurent Désaubry; Cedric Bardy; Christopher G Proud
Journal:  J Biol Chem       Date:  2020-05-19       Impact factor: 5.157

6.  TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodelling.

Authors:  Jianling Xie; Stuart P De Poi; Sean J Humphrey; Leanne K Hein; John B Bruning; Wenru Pan; Luke A Selth; Timothy J Sargeant; Christopher G Proud
Journal:  Cell Mol Life Sci       Date:  2021-04-08       Impact factor: 9.261

Review 7.  New Insights into Protein Hydroxylation and Its Important Role in Human Diseases.

Authors:  Giada Zurlo; Jianping Guo; Mamoru Takada; Wenyi Wei; Qing Zhang
Journal:  Biochim Biophys Acta       Date:  2016-09-20

8.  eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.

Authors:  Y Cheng; X Ren; Y Yuan; Y Shan; L Li; X Chen; L Zhang; Y Takahashi; J W Yang; B Han; J Liao; Y Li; H Harvey; A Ryazanov; G P Robertson; G Wan; D Liu; A F Chen; Y Tao; J-M Yang
Journal:  Oncogene       Date:  2016-05-16       Impact factor: 9.867

Review 9.  Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.

Authors:  Rui Liu; Christopher G Proud
Journal:  Acta Pharmacol Sin       Date:  2016-01-25       Impact factor: 6.150

Review 10.  Cellular adaptation to hypoxia through hypoxia inducible factors and beyond.

Authors:  Pearl Lee; Navdeep S Chandel; M Celeste Simon
Journal:  Nat Rev Mol Cell Biol       Date:  2020-03-06       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.